{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:25:06Z","timestamp":1794349506498,"version":"4.9.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:00:00Z","timestamp":1793577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Epidemiology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.gloepi.2026.100296","type":"journal-article","created":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:39:43Z","timestamp":1793810383000},"page":"100296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Twelve-month all-cause mortality after initial COVID-19 vaccination with Pfizer-BioNTech or mRNA-1273 among adults living in Florida: Statewide cohort study"],"prefix":"10.1016","volume":"12","author":[{"given":"Retsef","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Mansuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Ladapo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.gloepi.2026.100296_bb0005","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/S1473-3099(19)30742-X","article-title":"Vaccinology: time to change the paradigm?","volume":"20","author":"Benn","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.gloepi.2026.100296_bb0010","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41577-020-0338-x","article-title":"The non-specific and sex-differential effects of vaccines","volume":"20","author":"Aaby","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"8062","key":"10.1016\/j.gloepi.2026.100296_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-025-08800-x","article-title":"A natural experiment on the effect of herpes zoster vaccination on dementia","volume":"641","author":"Eyting","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.gloepi.2026.100296_bb0020","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.gloepi.2026.100296_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106733","article-title":"Randomized clinical trials of COVID-19 vaccines: do adenovirus-vector vaccines have beneficial non-specific effects?","volume":"26","author":"Benn","year":"2023","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.gloepi.2026.100296_bb0030","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1056\/NEJMc2306683","article-title":"Potential \"healthy vaccinee bias\" in a study of BNT162b2 vaccine against Covid-19","volume":"389","author":"Hoeg","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gloepi.2026.100296_bb0035","first-page":"374","article-title":"COVID-19 vaccination and all-cause and non-COVID-19 mortality. A revaluation of a study carried out in an Italian Province","volume":"47","author":"Berrino","year":"2023","journal-title":"Epidemiol Prev"},{"key":"10.1016\/j.gloepi.2026.100296_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-015-1154-y","article-title":"Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review","volume":"15","author":"Remschmidt","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.gloepi.2026.100296_bb0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.103690","article-title":"Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar","volume":"14","author":"Chemaitelly","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.gloepi.2026.100296_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.02.019","article-title":"Does the healthy vaccinee bias rule them all? Association of COVID-19 vaccination status and all-cause mortality from an analysis of data from 2.2 million individual health records","volume":"142","author":"Furst","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.gloepi.2026.100296_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.46822","article-title":"COVID-19 mRNA vaccination and 4-year all-cause mortality among adults aged 18 to 59 years in France","volume":"8","author":"Semenzato","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"7","key":"10.1016\/j.gloepi.2026.100296_bb0060","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrrheum.2015.30","article-title":"Active-comparator design and new-user design in observational studies","volume":"11","author":"Yoshida","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"10.1016\/j.gloepi.2026.100296_bb0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamainternmed.2022.2109","article-title":"Comparative safety of BNT162b2 and mRNA-1273 vaccines in a nationwide cohort of US veterans","volume":"182","author":"Dickerman","year":"2022","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.gloepi.2026.100296_bb0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2115463","article-title":"Comparative effectiveness of BNT162b2 and mRNA-1273 vaccines in U.S. Veterans","volume":"386","author":"Dickerman","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gloepi.2026.100296_bb0075","author":"About Florida SHOTS"},{"key":"10.1016\/j.gloepi.2026.100296_bb0080","author":"Confidential Data Requests for Research"},{"issue":"19","key":"10.1016\/j.gloepi.2026.100296_bb0085","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.gloepi.2026.100296_bb0090","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase","volume":"385","author":"El Sahly","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.gloepi.2026.100296_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"6","key":"10.1016\/j.gloepi.2026.100296_bb0100","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s11121-012-0339-5","article-title":"An introduction to sensitivity analysis for unobserved confounding in nonexperimental prevention research","volume":"14","author":"Liu","year":"2013","journal-title":"Prev Sci"},{"issue":"50","key":"10.1016\/j.gloepi.2026.100296_bb0105","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.15585\/mmwr.mm7050e2","article-title":"Booster and additional primary dose COVID-19 vaccinations among adults aged >\/=65 years - United States, August 13, 2021-November 19, 2021","volume":"70","author":"Fast","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"10.1016\/j.gloepi.2026.100296_bb0110","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.15585\/mmwr.mm7044e2","article-title":"The advisory committee on immunization practices' interim recommendations for additional primary and booster doses of COVID-19 vaccines - United States, 2021","volume":"70","author":"Mbaeyi","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.gloepi.2026.100296_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127870","article-title":"Effectiveness of spring 2024 (XBB.1.5) and autumn 2024 (JN.1) COVID-19 vaccination against hospitalisation in England","volume":"67","author":"Abdul Aziz","year":"2025","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.gloepi.2026.100296_bb0120","article-title":"Comparative effectiveness of three common SARS-COV-2 vaccines: a network meta-analysis of randomized trials","volume":"51","author":"Syed","year":"2025","journal-title":"Med Fam SEMERGEN"},{"issue":"3","key":"10.1016\/j.gloepi.2026.100296_bb0125","first-page":"1663","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna vaccines","volume":"25","author":"Meo","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.gloepi.2026.100296_bb0130","article-title":"Nanomaterial delivery systems for mRNA vaccines","volume":"9","author":"Buschmann","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.gloepi.2026.100296_bb0135","author":"Canada H"},{"key":"10.1016\/j.gloepi.2026.100296_bb0140","author":"Canada H"},{"key":"10.1016\/j.gloepi.2026.100296_bb0145","article-title":"Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: a target trial emulation study in the U.S. Veterans Affairs healthcare system","volume":"45","author":"Ioannou","year":"2022","journal-title":"EClinical Med"},{"issue":"10342","key":"10.1016\/j.gloepi.2026.100296_bb0150","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0140-6736(22)00791-7","article-title":"Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases","volume":"399","author":"Wong","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.gloepi.2026.100296_bb0155","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068665","article-title":"SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study","volume":"375","author":"Husby","year":"2021","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.gloepi.2026.100296_bb0160","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/ejhf.2978","article-title":"Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination","volume":"25","author":"Buergin","year":"2023","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.gloepi.2026.100296_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed7080196","article-title":"Cardiovascular manifestation of the BNT162b2 mRNA COVID-19 vaccine in adolescents","volume":"7","author":"Mansanguan","year":"2022","journal-title":"Trop Med Infect Dis"}],"container-title":["Global Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113326000556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590113326000556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:05:56Z","timestamp":1794348356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590113326000556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S2590113326000556"],"URL":"https:\/\/doi.org\/10.1016\/j.gloepi.2026.100296","relation":{},"ISSN":["2590-1133"],"issn-type":[{"value":"2590-1133","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Twelve-month all-cause mortality after initial COVID-19 vaccination with Pfizer-BioNTech or mRNA-1273 among adults living in Florida: Statewide cohort study","name":"articletitle","label":"Article Title"},{"value":"Global Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gloepi.2026.100296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100296"}}